Results 291 to 300 of about 297,465 (360)
Advancing immunotherapy for esophageal cancer: decoding the roles of PD-L1, TME, and tumor-intrinsic biomarkers. [PDF]
Ma J, Wu D, Liu Y, Zhang G.
europepmc +1 more source
Homoharringtonine (HHT), a clinically approved anti‐leukemic drug, directly binds the RNA‐binding protein EWSR1. HHT induces an allosteric conformational switch in the RNA recognition motif of EWSR1, driving self‐association and liquid–liquid phase separation (LLPS). The resulting condensates act as regulatory hubs that sequester the m6A reader YTHDF2,
Ting‐Ting Liu +17 more
wiley +1 more source
Perioperative nursing care strategies in esophageal cancer surgery: a mini-review. [PDF]
Li YF, Tao JH, Wang CC, Su DC.
europepmc +1 more source
Current landscape of immunotherapy in esophageal cancer: a literature review
Mohamad M Moughnyeh +3 more
openalex +1 more source
Fertility and Early Embryonic Development Toxicity of hzVSF‐v13 in Sprague–Dawley Rats
ABSTRACT Humanized virus suppressing factor–variant 13 (hzVSF‐v13), a monoclonal IgG4 antibody, is a potential therapeutic candidate for COVID‐19. Although fertility and embryonic developmental toxicity studies are crucial for the safety evaluation of new drugs, the toxicological profile of hzVSF‐v13 remains unexplored.
Ji‐Seong Jeong +10 more
wiley +1 more source
Impact of Preoperative Comprehensive Body Composition on Postoperative Outcomes in Patients with Esophageal Cancer. [PDF]
Shuto K +6 more
europepmc +1 more source
Survival analysis of additional radiotherapy after endoscopic therapy in patients with T1N0M0 esophageal cancer. [PDF]
Zhuang M +4 more
europepmc +1 more source

